M. Frey

发表

Free Calcium in Rat Papillary Muscle at Contraction Assessed with Ca-Selective Microelectrodes

R. Gasser, M. Frey, G. Fleckenstein-Grün, 1989, Angiology.

Restriction by Nitrendipine of Excessive Concentration of Free Intracellular Calcium Ions in Ventricular Myocardium of Hypertensive Rats

R. Gasser, M. Frey, G. Fleckenstein-Grün, 1988, Angiology.

Heparin-induced thrombocytopenia

G. Gerken, H. Just, M. Frey, 2000 .

Calcium antagonism and ACE inhibition. Two outstandingly effective means of interference with cardiovascular calcium overload, high blood pressure, and arteriosclerosis in spontaneously hypertensive rats.

M. Frey, G. Fleckenstein-Grün, A. Fleckenstein, 1989, American journal of hypertension.

Calcium antagonist drugs in hypertensive patients with angina pectoris.

M. Zehender, H. Just, M. Frey, 1996, European heart journal.

Excessive mural calcium overload — A predominant causal factor in the development of stenosing coronary plaques in humans

M. Frey, G. Fleckenstein-Grün, F. Thimm, 1990, Cardiovascular Drugs and Therapy.

Amlodipine, a new 1,4-dihydropyridine calcium antagonist with a particularly strong antihypertensive profile.

M. Frey, G. Fleckenstein-Grün, A. Fleckenstein, 1989, The American journal of cardiology.

Role of calcium antagonists in progression of arteriosclerosis. Evidence from animal experiments and clinical experience. Part II. Clinical experience with preventive effects of calcium channel blockers in atheromatous coronary artery disease.

H. Just, M. Frey, 1994, Basic research in cardiology.

Protection of Arterial and Arteriolar Wall Structure by Specific Calcium Antagonists a

M. Frey, G. Fleckenstein-Grün, A. Fleckenstein, 1988, Annals of the New York Academy of Sciences.

Experimental basis of the long-term therapy of arterial hypertension with calcium antagonists.

M. Frey, G. Fleckenstein-Grün, A. Fleckenstein, 1985, The American journal of cardiology.

Heparin-induced thrombocytopenia

G. Gerken, H. Just, M. Frey, 2000 .

Progression and Regression by Verapamil of Vitamin D3-Induced Calcific Medial Degeneration in Coronary Arteries of Rats

M. Frey, G. Fleckenstein-Grün, F. Thimm, 1995, Journal of cardiovascular pharmacology.

Future directions in the use of calcium antagonists.

M. Frey, G. Fleckenstein-Grün, A. Fleckenstein, 1987, The American journal of cardiology.

Experimental Vasoprotection by Calcium Antagonists Against Calcium‐Mediated Arteriosclerotic Alterations

M. Frey, G. Fleckenstein-Grün, F. Thimm, 1994, Journal of cardiovascular pharmacology.

Role of calcium in arteriosclerosis--experimental evaluation of antiarteriosclerotic potencies of Ca antagonists. Study Group for Calcium Antagonism.

M. Frey, G. Fleckenstein-Grün, F. Thimm, 1994, Basic research in cardiology.

Misinterpretation of coronary cholesterol atheromata in cholesterol-fed rabbits as suitable model for conventional human coronary plaques.

M. Frey, G. Fleckenstein-Grün, F. Thimm, 1994, Advances in experimental medicine and biology.

Antihypertensive and arterial anticalcinotic effects of calcium antagonists.

M. Frey, G. Fleckenstein-Grün, A. Fleckenstein, 1986, The American journal of cardiology.

Calcium antagonists: mechanisms and therapeutic uses

M. Frey, G. Fleckenstein-Grün, A. Fleckenstein, 1984 .

The role of calcium in the pathogenesis of experimental arteriosclerosis

M. Frey, G. Fleckenstein-Grün, A. Fleckenstein, 1987 .

Prevention by Verapamil of Isoproterenol-Induced Hypertrophic Cardiomyopathy in Rats

M. Frey, A. Fleckenstein, J. Keidel, 1982 .

Cardiovascular Protection by Calcium Antagonists

M. Frey, G. Fleckenstein-Grün, A. Fleckenstein, 1985 .

Interdependence of Antihypertensive, Anticalcinotic, and Antiarteriosclerotic Effects of Calcium Antagonists — Model Experiments on Spontaneously Hypertensive Rats (SHR)

M. Frey, G. Fleckenstein-Grün, A. Fleckenstein, 1985 .

Anti-Arteriosclerotic Effects of Calcium Antagonists: Do Calcium Antagonists Inhibit Cholesterol Accumulation in Coronary Arteries of Cholesterol-Fed Rabbits?

M. Frey, G. Fleckenstein-Grün, F. Thimm, 1993 .

Arterial Calcium Overload: A Cardinal Element in the Development of Arteriosclerosis and Vasoprotection with Calcium Antagonists

M. Frey, G. Fleckenstein-Grün, F. Thimm, 1991 .

Calcium Overload — An Important Cellular Mechanism in Hypertension and Arteriosclerosis

M. Frey, G. Fleckenstein-Grün, F. Thimm, 2012, Drugs.

Consequences of uncontrolled calcium entry and its prevention with calcium antagonists.

M. Frey, G. Fleckenstein-Grün, A. Fleckenstein, 1983, European heart journal.

Evaluation of transmyocardial laser revascularization by following objective parameters of perfusion and ventricular function.

E. Nitzsche, F. Beyersdorf, S. Hoegerle, 2000, The Thoracic and cardiovascular surgeon.

Antihypertensive, Anticalcinotic, and Antiarteriosclerotic Properties of Anipamil, a Long‐Acting New Derivative of Verapamil

M. Frey, G. Fleckenstein-Grün, A. Fleckenstein, 1989, Journal of Cardiovascular Pharmacology.

Peculiarities of vitamin d3 induced excessive calcium accumulation in different rat arteries

M. Frey, F. Thimm, A. Fleckenstein, 1990 .

Experimental Antiarteriosclerotic Effects of Calcium Antagonists

M. Frey, G. Fleckenstein-Grün, F. Thimm, 1990, Journal of clinical pharmacology.

Role of calcium antagonists in progression of arteriosclerosis. Evidence from animal experiments and clinical experience. Part I. Preventive effects of calcium antagonists in animal experiments.

H. Just, M. Frey, 1994, Basic research in cardiology.

New aspects of excitation-contraction coupling in cardiac muscle: two types of Ca++ entry promotion with and without involvement of cyclic AMP and Mg++ ions.

M. Frey, A. Fleckenstein, W. Wagner, 1987, Basic research in cardiology.